ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Juvenile idiopathic arthritis-enthesitis (ERA) and outcomes"

  • Abstract Number: 409 • 2016 ACR/ARHP Annual Meeting

    Discordance Between Physician, Patient, and Parent Disease Assessment Scores in Juvenile Idiopathic Arthritis

    Emily Fox1, Joyce Hsu1, Tzielan Lee2, Christy Sandborg3 and Julia F Simard4, 1Pediatric Rheumatology, Stanford University, Palo Alto, CA, 2Dept of Pediatric Rheumatology, Stanford Univ School of Med, Palo Alto, CA, 3Pediatric Rheumatology PTD, Stanford Medical Center, Palo Alto, CA, 4Division of Epidemiology, Health Research and Policy Department, and Division of Immunology & Rheumatology, Department of Medicine, Stanford School of Medicine, Stanford, CA

    Background/Purpose: Global assessment scores are increasing important in assessing disease activity by physicians and patients/parents (PGAmd, PGApatient/parent). The purpose of this study was to determine…
  • Abstract Number: 2448 • 2015 ACR/ARHP Annual Meeting

    Flare Definitions for Juvenile Idiopathic Arthritis (JIA) Based on ACR Core Set Variables and Patient Reported Outcomes: Results from the Research in Arthritis in Canadian Children-Emphasizing Outcomes Prospective Cohort

    Vinay Shivamurthy1, Deborah M. Levy2, Gilles Boire3, Karen N Watanabe Duffy4, Elizabeth Stringer5, Rosie Scuccimarri6, Rae S.M. Yeung7, Adam M. Huber8, Kiem Oen9, Natalie Shiff10, Lori B. Tucker11, Roberta Berard12, Kimberly Morishita13, Ciarán M. Duffy14 and Jaime Guzman15, 1Pediatrics/Rheumatology, British Columbia Children's Hospital, Vancouver, BC, Canada, 2Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, 3Department of Medicine/Division of Rheumatology, Université de Sherbrooke, Sherbrooke, QC, Canada, 4Rheumatology, Children's Hospital of Eastern Ontario and University of Ottawa, Ottawa, ON, Canada, 5Department of Rheumatology, IWK Health Centre, Halifax, NS, Canada, 6Pediatrics, McGill University, Montréal, QC, Canada, 7Pediatrics, Immunology and Medical Science, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada, 8Pediatric rheumatology, IWK Health Centre, Halifax, NS, Canada, 9University of Manitoba, Winnipeg, MB, Canada, 10Pediatric Rheumatology, University of Saskatchewan, Saskatoon, SK, Canada, 11Rheumatology, BC Children's Hospital, Vancouver, BC, Canada, 12Children's Hospital of Western Ontario, London, ON, Canada, 13Pediatric Rheumatology, BC's Children's Hospital, Vancouver, BC, Canada, 14Children's Hospital of Eastern Ontario and University of Ottawa, Ottawa, ON, Canada, 15Rheumatology, Division of Rheumatology, BC Children's Hospital, Vancouver, BC, Canada

    Background/Purpose: A valid flare definition is needed in clinical practice to identify a clinically relevant worsening which will guide us make treatment decisions. While the…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology